William Blair has added Terence Tan as managing director in the firm’s Healthcare investment banking team. Based in New York, Tan will focus on providing biopharma companies with comprehensive advisory services.

“It is my pleasure to welcome Terence to William Blair’s Healthcare investment banking practice and its biopharma group,” said Steve Tole, head of Healthcare investment banking at William Blair. “Our team of committed bankers provides strategic investors and financial sponsors with unique sector expertise and tailored advisory services across the fast-paced biopharma industry, including its various complex subsectors, and Terence’s addition will further deepen our capabilities and commitment to our clients.”

Tan brings more than 19 years of experience in biopharma investment banking, serving companies across all stages of development. He joins from Cantor Fitzgerald, where he served as a managing director focused on providing biopharma companies with investment banking guidance, including debt, equity, and equity-linked securities, private placements, and mergers and acquisitions. Tan has worked closely with venture capital firms, hedge funds, and mutual funds to unlock sophisticated financing solutions, having also held roles with Jefferies and UBS. He received his B.S. from Cornell University.

“William Blair is well-known for its premier investment banking platform, thoughtful client service, and innovative solutions to leading biopharma companies,” Tan said. “I am thrilled to join such a well-respected team and to deliver outstanding outcomes for our clients.”